世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034639

核医学の世界市場(2023-2027)

TechNavio

Global Nuclear Medicine Market 2023-2027

発刊日 2023/03/15

言語英語

体裁PDF/169ページ

ライセンス/価格169ページ

0000034639

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、核医学市場を分析します。

世界の核医学市場は、予測期間中に約16.48 %のCAGRで拡大し、2022年から2027年の間に80億5,789万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、SPECT/CTハイブリッドイメージングシステムの採用拡大、疾患の早期発見を目的とした核医学の使用増加、がん患者の増加やがん市場への投資増加などが牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 放射線治療
      ◇ SPECT・PET機器
    ➣ 用途別
      ◇ 腫瘍
      ◇ 心臓病学
      ◇ 神経
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ アジア
      ◇ ヨーロッパ
      ◇ その他の地域

本調査では、今後数年間の核医学市場の成長を促進する主な理由の一つとして、放射性医薬品の潜在的な利益と比較して、副作用が少ないことを挙げています。また、ハイブリッドイメージングの用途を広げるための研究開発、新しい放射性医薬品の絶え間ない発見と開発が、市場の大きな需要につながると考えています。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 核医学の市場規模
  • 核医学の市場予測
  • 核医学市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な核医学市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Bayer AG
    ➣ Bracco Spa
    ➣ Cardinal Health Inc.
    ➣ Eckert and Ziegler AG
    ➣ ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
    ➣ GE Healthcare Technologies Inc.
    ➣ IBA Radiopharma Solutions
    ➣ Jubilant Pharmova Ltd.
    ➣ Koninklijke Philips NV
    ➣ Lantheus Holdings Inc.
    ➣ Mallinckrodt Pl
    ➣ Medi-Radiopharma
    ➣ Mirion Technologies Inc.
    ➣ Necsa, Novartis A
    ➣ Siemens Healthineers AG
    ➣ Sirtex Medical Pty Ltd.
    ➣ Telix Pharmaceuticals Ltd.
    ➣ Tema Sinergie SpA
    ➣ Imaging Solutions LLC.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global nuclear medicine market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Radiotherapeutics - Market size and forecast 2022-2027
Exhibit 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
6.4 Equipment (SPECT and PET) - Market size and forecast 2022-2027
Exhibit 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Oncology - Market size and forecast 2022-2027
Exhibit 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
7.4 Cardiology - Market size and forecast 2022-2027
Exhibit 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
7.5 Neurology - Market size and forecast 2022-2027
Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Application
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 115: Bayer AG - Overview
Exhibit 116: Bayer AG - Business segments
Exhibit 117: Bayer AG - Key news
Exhibit 118: Bayer AG - Key offerings
Exhibit 119: Bayer AG - Segment focus
12.4 Bracco Spa
Exhibit 120: Bracco Spa - Overview
Exhibit 121: Bracco Spa - Product / Service
Exhibit 122: Bracco Spa - Key offerings
12.5 Cardinal Health Inc.
Exhibit 123: Cardinal Health Inc. - Overview
Exhibit 124: Cardinal Health Inc. - Business segments
Exhibit 125: Cardinal Health Inc. - Key news
Exhibit 126: Cardinal Health Inc. - Key offerings
Exhibit 127: Cardinal Health Inc. - Segment focus
12.6 Eckert and Ziegler AG
Exhibit 128: Eckert and Ziegler AG - Overview
Exhibit 129: Eckert and Ziegler AG - Business segments
Exhibit 130: Eckert and Ziegler AG - Key news
Exhibit 131: Eckert and Ziegler AG - Key offerings
Exhibit 132: Eckert and Ziegler AG - Segment focus
12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
12.8 GE Healthcare Technologies Inc.
Exhibit 136: GE Healthcare Technologies Inc. - Overview
Exhibit 137: GE Healthcare Technologies Inc. - Business segments
Exhibit 138: GE Healthcare Technologies Inc. - Key offerings
Exhibit 139: GE Healthcare Technologies Inc. - Segment focus
12.9 IBA Radiopharma Solutions
Exhibit 140: IBA Radiopharma Solutions - Overview
Exhibit 141: IBA Radiopharma Solutions - Business segments
Exhibit 142: IBA Radiopharma Solutions - Key offerings
Exhibit 143: IBA Radiopharma Solutions - Segment focus
12.10 Jubilant Pharmova Ltd.
Exhibit 144: Jubilant Pharmova Ltd. - Overview
Exhibit 145: Jubilant Pharmova Ltd. - Business segments
Exhibit 146: Jubilant Pharmova Ltd. - Key news
Exhibit 147: Jubilant Pharmova Ltd. - Key offerings
Exhibit 148: Jubilant Pharmova Ltd. - Segment focus
12.11 Koninklijke Philips NV
Exhibit 149: Koninklijke Philips NV - Overview
Exhibit 150: Koninklijke Philips NV - Business segments
Exhibit 151: Koninklijke Philips NV - Key news
Exhibit 152: Koninklijke Philips NV - Key offerings
Exhibit 153: Koninklijke Philips NV - Segment focus
12.12 Mallinckrodt Plc
Exhibit 154: Mallinckrodt Plc - Overview
Exhibit 155: Mallinckrodt Plc - Business segments
Exhibit 156: Mallinckrodt Plc - Key news
Exhibit 157: Mallinckrodt Plc - Key offerings
Exhibit 158: Mallinckrodt Plc - Segment focus
12.13 Medi-Radiopharma
Exhibit 159: Medi-Radiopharma - Overview
Exhibit 160: Medi-Radiopharma - Product / Service
Exhibit 161: Medi-Radiopharma - Key offerings
12.14 Necsa
Exhibit 162: Necsa - Overview
Exhibit 163: Necsa - Product / Service
Exhibit 164: Necsa - Key offerings
12.15 Novartis AG
Exhibit 165: Novartis AG - Overview
Exhibit 166: Novartis AG - Business segments
Exhibit 167: Novartis AG - Key offerings
Exhibit 168: Novartis AG - Segment focus
12.16 Siemens Healthineers AG
Exhibit 169: Siemens Healthineers AG - Overview
Exhibit 170: Siemens Healthineers AG - Business segments
Exhibit 171: Siemens Healthineers AG - Key news
Exhibit 172: Siemens Healthineers AG - Key offerings
Exhibit 173: Siemens Healthineers AG - Segment focus
12.17 Sirtex Medical Pty Ltd.
Exhibit 174: Sirtex Medical Pty Ltd. - Overview
Exhibit 175: Sirtex Medical Pty Ltd. - Product / Service
Exhibit 176: Sirtex Medical Pty Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bayer AG - Overview
Exhibits116: Bayer AG - Business segments
Exhibits117: Bayer AG - Key news
Exhibits118: Bayer AG - Key offerings
Exhibits119: Bayer AG - Segment focus
Exhibits120: Bracco Spa - Overview
Exhibits121: Bracco Spa - Product / Service
Exhibits122: Bracco Spa - Key offerings
Exhibits123: Cardinal Health Inc. - Overview
Exhibits124: Cardinal Health Inc. - Business segments
Exhibits125: Cardinal Health Inc. - Key news
Exhibits126: Cardinal Health Inc. - Key offerings
Exhibits127: Cardinal Health Inc. - Segment focus
Exhibits128: Eckert and Ziegler AG - Overview
Exhibits129: Eckert and Ziegler AG - Business segments
Exhibits130: Eckert and Ziegler AG - Key news
Exhibits131: Eckert and Ziegler AG - Key offerings
Exhibits132: Eckert and Ziegler AG - Segment focus
Exhibits133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibits134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibits135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
Exhibits136: GE Healthcare Technologies Inc. - Overview
Exhibits137: GE Healthcare Technologies Inc. - Business segments
Exhibits138: GE Healthcare Technologies Inc. - Key offerings
Exhibits139: GE Healthcare Technologies Inc. - Segment focus
Exhibits140: IBA Radiopharma Solutions - Overview
Exhibits141: IBA Radiopharma Solutions - Business segments
Exhibits142: IBA Radiopharma Solutions - Key offerings
Exhibits143: IBA Radiopharma Solutions - Segment focus
Exhibits144: Jubilant Pharmova Ltd. - Overview
Exhibits145: Jubilant Pharmova Ltd. - Business segments
Exhibits146: Jubilant Pharmova Ltd. - Key news
Exhibits147: Jubilant Pharmova Ltd. - Key offerings
Exhibits148: Jubilant Pharmova Ltd. - Segment focus
Exhibits149: Koninklijke Philips NV - Overview
Exhibits150: Koninklijke Philips NV - Business segments
Exhibits151: Koninklijke Philips NV - Key news
Exhibits152: Koninklijke Philips NV - Key offerings
Exhibits153: Koninklijke Philips NV - Segment focus
Exhibits154: Mallinckrodt Plc - Overview
Exhibits155: Mallinckrodt Plc - Business segments
Exhibits156: Mallinckrodt Plc - Key news
Exhibits157: Mallinckrodt Plc - Key offerings
Exhibits158: Mallinckrodt Plc - Segment focus
Exhibits159: Medi-Radiopharma - Overview
Exhibits160: Medi-Radiopharma - Product / Service
Exhibits161: Medi-Radiopharma - Key offerings
Exhibits162: Necsa - Overview
Exhibits163: Necsa - Product / Service
Exhibits164: Necsa - Key offerings
Exhibits165: Novartis AG - Overview
Exhibits166: Novartis AG - Business segments
Exhibits167: Novartis AG - Key offerings
Exhibits168: Novartis AG - Segment focus
Exhibits169: Siemens Healthineers AG - Overview
Exhibits170: Siemens Healthineers AG - Business segments
Exhibits171: Siemens Healthineers AG - Key news
Exhibits172: Siemens Healthineers AG - Key offerings
Exhibits173: Siemens Healthineers AG - Segment focus
Exhibits174: Sirtex Medical Pty Ltd. - Overview
Exhibits175: Sirtex Medical Pty Ltd. - Product / Service
Exhibits176: Sirtex Medical Pty Ltd. - Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations

この商品のレポートナンバー

0000034639

TOP